Related Experiment Video

Updated: Aug 9, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[Therapy of pneumonia in children with mezlocillin (author's transl)]

G Weippl

    Arzneimittel-Forschung
    |January 1, 1979
    PubMed

    Insights

    Pneumonia in children is treated with antibiotics, and simple tests can distinguish between bacterial and viral infections. This approach led to rapid recovery in most pediatric pneumonia cases.

    Area of Science:

    • Pediatric infectious diseases
    • Clinical microbiology
    • Diagnostic immunology

    Context:

    • Pneumonia in children necessitates prompt antibiotic intervention.
    • Identifying the specific causative organism is diagnostically challenging and often impractical for immediate therapeutic decisions.
    • Simple laboratory tests, including BSR (erythrocyte sedimentation rate), neutrophil count, and unsegmented neutrophil count, aid in differentiating bacterial from viral etiologies.

    Purpose:

    • To evaluate the efficacy of a diagnostic approach using simple laboratory examinations to guide antibiotic treatment in pediatric pneumonia.
    • To assess the feasibility of retrospectively evaluating antibiotic treatment effectiveness based on these diagnostic markers.

    Summary:

    • A study involving 72 infants and children with pneumonia utilized simple hematological tests to guide treatment.
    • Diagnoses included primary pneumonia (49 cases), pneumonia with whooping cough (12 cases), congenital defects (4 cases), Salmonella-induced septicopyemia (1 case), and infections with reduced immune defense (6 cases).
    • All patients, except one with an underdeveloped immune system, showed rapid clinical improvement within 5-7 days, with only two cases experiencing a rash as a side effect.

    Impact:

    • This diagnostic strategy facilitates effective and rapid antibiotic treatment for pediatric pneumonia.
    • The findings support the use of basic laboratory parameters for both guiding and retrospectively assessing antibiotic therapy in children.
    • The study highlights a successful treatment protocol with minimal adverse effects in a diverse cohort of pediatric pneumonia patients.

    More Related Videos

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

    Published on: January 2, 2017

    Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

    Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

    Published on: March 1, 2024

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...